Page 183 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

Detection Techniques and Clinical Relevance of ANCA Testing … 159

[8] Holle, J. U., Herrmann, K., Gross, W. L., et al. Comparative analysis of different
commercial ELISA systems for detection of anti-neutrophil cytoplasm antibodies in
ANCA-associated vasculitides. Clin. Exp. Rheumatol. 2012; 30(Suppl. 70):S66-S69.

[9] Boomsma, M. M., Damoiseaux, F. G. M. C., Stegeman, C. A., et al. Image analysis: a
novel approach for the quantification of ANCA levels in patients with Wegener`s
granulomatosis. J. Immunol. Methods 2003. 274.27-35.

[10] Trevisin, M., Pollock, W., Savige, J. Evaluation of a multiplex flow cytometric
immunoassay to detect PR3- and MPO-ANCA in active and treated vasculitis, and in
inflammatory bowel disease. J. Immunol. Methods 2008. 336:104-112.

[11] Sinclair, D., Saas, M., Stevens, J. M. The effect of a symptom related „„gating policy??
on ANCA requests in routine clinical practice. J. Clin. Pathol. 2004; 57:131-134.

[12] Arnold, D. F., Timms, A., Luqmani, R., et al. Does a gating policy for ANCA overlook
patients with ANCA associated vasculitis? An audit of 263 patients. J. Clin. Pathol.
2010; 63:678-680.

[13] Tomasson, G., Grayson, P. C., Mahr, A. D., et al. Value of ANCA measurements
during remission to predict a relapse of ANCA-associated vasculitis-a meta-analysis.
Rheumatology 2012; 51:100-109.

[14] Franssen, C., Gans, R., Kallenberg, C., et al. Disease spectrum of patients with
antineutrophil cytoplasmic autoantibodies of defined specificity: distinct differences
between patients with anti-proteinase 3 and anti-myeloperoxidase autoantibodies. J.
Intern. Med. 1998; 244, 209-216.

[15] Schönermarck, U., Lamprecht, P., Csernok, E., et al. Prevalence and spectrum of
rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies
(ANCA) and myeloperoxidase-ANCA. Rheumatology 2001; 40, 178-184.

[16] Hauer, H. A., Bajema, I. M., van Houwelingen, H. C., Ferrario, F., et al. Renal
histology in ANCA-associated vasculitis: differences between diagnostic and serologic
subgroups. Kidney Int. 2002; 61, 80-89.

[17] Lyons, P. A., Rayner, T. F., Trivedi, S., et al. Genetically distinct subsets within
ANCA-associated vasculitis. N. Engl. J. Med. 2012; 367:214-223.

Complimentary Contributor Copy